Inventor · disambiguated record
Yongqin Wan
Also filed as: WAN YONGQIN
27 granted patents·14 pending applications·219 citations·filing 2004–2022
96Inventor score
Top patents by PatentIndex Score
41 records- 0195US8501758B2Compounds and compositions as protein kinase inhibitorsHUANG SHENLIN·Filed 2010·Granted Aug 6, 2013·40 cites·12 claims
- 0292US9850230B2Compounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Dec 26, 2017·7 cites·9 claims
- 0392US9593100B2Compounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Mar 14, 2017·7 cites·25 claims
- 0492US9593099B2Compounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Mar 14, 2017·7 cites·2 claims
- 0592US7893074B22, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disordersNOVARTIS AG·Filed 2004·Granted Feb 22, 2011·55 cites·9 claims
- 0691US9850229B2Compounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Dec 26, 2017·5 cites·20 claims
- 0789US9580426B2Compounds that expand hematopoietic stem cellsBOITANO ANTHONY E·Filed 2013·Granted Feb 28, 2017·13 cites·20 claims
- 0889US9314464B2Compounds and compositions as protein kinase inhibitorsNOVARTIS AG·Filed 2013·Granted Apr 19, 2016·7 cites·27 claims
- 0988US8927281B2Method for expanding hematopoietic stem cellsBOITANO ANTHONY E·Filed 2009·Granted Jan 6, 2015·11 cites·22 claims
- 1087US10005761B2Compounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Jun 26, 2018·3 cites·28 claims
- 1187US7713958B2Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2008·Granted May 11, 2010·8 cites·10 claims
- 1286US10787480B2Cytotoxic peptides and conjugates thereofNOVARTIS AG·Filed 2019·Granted Sep 29, 2020·2 cites·11 claims
- 1386US8507491B2Compounds and compositions as hedgehog pathway inhibitorsCHENG DAI·Filed 2009·Granted Aug 13, 2013·11 cites·18 claims
- 1483US8178563B2Compounds and compositions as hedgehog pathway modulatorsGAO WENQI·Filed 2007·Granted May 15, 2012·12 cites·12 claims
- 1582US10392421B2Cytotoxic peptides and conjugates thereofNOVARTIS AG·Filed 2018·Granted Aug 27, 2019·3 cites·12 claims
- 1682US2023116233A1Compounds And Compositions As Protein Kinase InhibitorsARRAY BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 1781US10576080B2Compounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Mar 3, 2020·1 cites·22 claims
- 1881US10568884B2Compounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Feb 25, 2020·1 cites·14 claims
- 1981US9884817B2Auristatin derivatives and conjugates thereofGEIERSTANGER BERNHARD HUBERT·Filed 2015·Granted Feb 6, 2018·4 cites·17 claims
- 2080USRE49556ECompounds and compositions as protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2021·Granted Jun 20, 2023·0 cites·15 claims
- 2180US7928133B2Compounds and compositions as hedgehog signaling pathway modulatorsIRM LLC·Filed 2007·Granted Apr 19, 2011·5 cites·6 claims
- 2278US9988420B2Cytotoxic peptides and conjugates thereofGEIERSTANGER BERNHARD HUBERT·Filed 2014·Granted Jun 5, 2018·4 cites·29 claims
- 2375US9216964B2Hedgehog pathway modulatorsCHENG DAI·Filed 2013·Granted Dec 22, 2015·3 cites·18 claims
- 2475US8101608B2Compounds and compositions as protein kinase inhibitorsWAN YONGQIN·Filed 2005·Granted Jan 24, 2012·5 cites·10 claims
- 2573US7423031B2Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2004·Granted Sep 9, 2008·5 cites·8 claims
- 2673US2020323852A1Compounds And Compositions As Protein Kinase InhibitorsARRAY BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 2770US2021187033A1Compounds that expand hematopoietic stem cellsNOVARTIS AG·Filed 2020·Application pending·0 cites
- 2856US2017239296A1Compounds that expand hematopoietic stem cellsNOVARTIS AG·Filed 2017·Application pending·0 cites
- 2952US8178526B2Compounds and compositions as ITPKb inhibitorsBURSULAYA BADRY·Filed 2008·Granted May 15, 2012·0 cites·7 claims
- 3050US2021228731A1Antibody drug conjugates for ablating hematopoietic stem cellsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 3150US2011263610A1Compounds and compositions as itpkb inhibitorsIRM LLC·Filed 2009·Application pending·0 cites
- 3249US10280139B2Cytotoxic peptides and conjugates thereofNOVARTIS AG·Filed 2017·Granted May 7, 2019·0 cites·20 claims
- 3349US2021170043A1Dc-sign antibody conjugates comprising sting agonistsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 3445US2008227783A15-Substituted Thiazol-2-Yl Amino Compounds and Compositions as Protein Kinase InhibitorsIRM LLC·Filed 2006·Application pending·0 cites
- 3545US2011098280A12,4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disordersNOVARTIS AG·Filed 2011·Application pending·0 cites
- 3644US2009221547A1Immunosuppressant Compounds and CompositionsIRM LLC·Filed 2006·Application pending·0 cites
- 3743US2012196849A1Compounds and compositions as hedgehog pathway modulatorsGAO WENQI·Filed 2012·Application pending·0 cites
- 3841US2012202782A1Compounds and compositions as itpkb inhibitorsBURSULAYA BADRY·Filed 2012·Application pending·0 cites
- 3940US2009306039A1Compounds and compositions as itpkb inhibitorsPAN SHIFENG·Filed 2007·Application pending·0 cites
- 4039US9181238B2N-(pyridin-2-yl)sulfonamides and compositions thereof as protein kinase inhibitorsPAN SHIFENG·Filed 2011·Granted Nov 10, 2015·0 cites·11 claims
- 4139US2019194315A1Antibody drug conjugatesABRAMS TINYA·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yongqin Wan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →